{
    "organizations": [],
    "uuid": "6bced05cecf5c8586519f81172d36966fd161ea0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novan-announces-first-patient-dose/brief-novan-announces-first-patient-dosed-in-phase-2-molluscum-contagiosum-trial-with-sb206-idUSASB0C2DJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Novan Announces First Patient Dosed In Phase 2 Molluscum Contagiosum Trial With SB206",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - Novan Inc:\n* NOVAN ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 MOLLUSCUM CONTAGIOSUM TRIAL WITH SB206\n* NOVAN INC - TOP LINE RESULTS ARE TARGETED FOR Q4 OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-25T22:15:00.000+02:00",
    "crawled": "2018-01-26T21:19:07.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "novan",
        "inc",
        "novan",
        "announces",
        "first",
        "patient",
        "dosed",
        "phase",
        "molluscum",
        "contagiosum",
        "trial",
        "sb206",
        "novan",
        "inc",
        "top",
        "line",
        "result",
        "targeted",
        "q4",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}